Epsilon Indi Ba, Bb: a detailed study of the nearest known brown dwarfs

The discovery of epsilon Indi Ba, Bb, a binary brown dwarf system very close to the Sun, makes possible a concerted campaign to characterise the physical parameters of two T dwarfs. Recent observations suggest substellar atmospheric and evolutionary models may be inconsistent with observations, but there have been few conclusive tests to date. We therefore aim to characterise these benchmark brown dwarfs to place constraints on such models. We have obtained high angular resolution optical, near-infrared, and thermal-infrared imaging and medium-resolution (up to R~5000) spectroscopy of epsilon Indi Ba, Bb with the ESO VLT and present VRIzJHKL'M' broad-band photometry and 0.63--5.1 micron spectroscopy of the individual components. Furthermore, we use deep AO-imaging to place upper limits on the (model-dependent) mass of any further system members. We derive luminosities of log L/L_sun = -4.699+/-0.017 and -5.232+/-0.020 for epsilon Indi Ba, Bb, respectively, and using the dynamical system mass and COND03 evolutionary models predict a system age of 3.7--4.3 Gyr, in excess of previous estimates and recent predictions from observations of these brown dwarfs. Moreover, the effective temperatures of 1352--1385 K and 976--1011 K predicted from the COND03 evolutionary models, for epsilon Indi Ba and Bb respectively, are in disagreement with those derived from the comparison of our data with the BT-Settl atmospheric models where we find effective temperatures of 1300--1340 K and 880--940 K, for epsilon Indi Ba and Bb respectively, with surface gravities of log g=5.25 and 5.50. Finally, we show that spectroscopically determined effective temperatures and surface gravities for ultra-cool dwarfs can lead to underestimated masses even where precise luminosity constraints are available.Comment: 27 pages, 30 figures, 9 tables, accepted for publication in Astronomy and Astrophysic

Studies of micronuclei and other nuclear abnormalities in red blood cells of Colossoma macropomum exposed to methylmercury

The frequencies of micronuclei (MN) and morphological nuclear abnormalities (NA) in erythrocytes in the peripheral blood of tambaqui (Colossoma macropomum), treated with 2 mg.L−1 methylmercury (MeHg), were analyzed. Two groups (nine specimens in each) were exposed to MeHg for different periods (group A - 24 h; group B - 120 h). A third group served as negative control (group C, untreated; n = 9). Although, when compared to the control group there were no significant differences in MN frequency in the treated groups, for NA, the differences between the frequencies of group B (treated for 120 h) and the control group were extremely significant (p < 0.02), thus demonstrating the potentially adverse effects of MeHg on C. macropomum erythrocytes after prolonged exposure

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

The role of competition in structuring primate communities under different productivity regimes in the Amazon

The factors responsible for the formation of Amazonian primate communities are not well understood. Here we investigated the influence of interspecific competition in the assembly of these communities, specifically whether they follow an assembly rule known as "favored states". According to this rule, interspecific competition influences final species composition, resulting in functional groups that are equally represented in the community.We compiled presence-absence data for primate species at 39 Amazonian sites in Brazil, contrasting two regions with distinct productivity regimes: the eutrophic Juruá River basin and the oligotrophic Negro River basin. We tested two hypotheses: that interspecific competition is a mechanism that influences the structure of Amazonian primate communities, and that competition has had a greater influence on the structure of primate communities in regions with low productivity, where resources are more limited. We used null models to test the statistical significance of the results, and found a non-random pattern compatible with the favored states rule in the two regions. Our findings suggest that interspecific competition is an important force driving primate community assembly regardless of productivity regimes